Anxiety and Stress Research Unit, Beer-Sheva Mental Health Center, The State of Israel Ministry of Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Neuropsychopharmacology. 2012 Jan;37(2):350-63. doi: 10.1038/npp.2011.230. Epub 2011 Oct 5.
Converging evidence implicates the regulatory neuropeptide Y (NPY) in anxiety- and depression-related behaviors. The present study sought to assess whether there is an association between the magnitude of behavioral responses to stress and patterns of NPY in selected brain areas, and subsequently, whether pharmacological manipulations of NPY levels affect behavior in an animal model of PTSD. Animals were exposed to predator-scent stress for 15 min. Behaviors were assessed with the elevated plus maze and acoustic startle response tests 7 days later. Preset cutoff criteria classified exposed animals according to their individual behavioral responses. NPY protein levels were assessed in specific brain regions 8 days after the exposure. The behavioral effects of NPY agonist, NPY-Y1-receptor antagonist, or placebo administered centrally 1 h post-exposure were evaluated in the same manner. Immunohistochemical technique was used to detect the expression of the NPY, NPY-Y1 receptor, brain-derived neurotrophic factor, and GR 1 day after the behavioral tests. Animals whose behavior was extremely disrupted (EBR) selectively displayed significant downregulation of NPY in the hippocampus, periaqueductal gray, and amygdala, compared with animals whose behavior was minimally (MBR) or partially (PBR) disrupted, and with unexposed controls. One-hour post-exposure treatment with NPY significantly reduced prevalence rates of EBR and reduced trauma-cue freezing responses, compared with vehicle controls. The distinctive pattern of NPY downregulation that correlated with EBR as well as the resounding behavioral effects of pharmacological manipulation of NPY indicates an intimate association between NPY and behavioral responses to stress, and potentially between molecular and psychopathological processes, which underlie the observed changes in behavior. The protective qualities attributed to NPY are supported by the extreme reduction of its expression in animals severely affected by the stressor and imply a role in promoting resilience and/or recovery.
越来越多的证据表明,调节神经肽 Y(NPY)与焦虑和抑郁相关的行为有关。本研究旨在评估应激反应的行为幅度与特定脑区 NPY 模式之间是否存在关联,以及随后 NPY 水平的药物干预是否会影响创伤后应激障碍的动物模型中的行为。动物暴露于捕食者气味应激 15 分钟。7 天后,通过高架十字迷宫和听觉惊跳反应测试评估行为。根据个体行为反应的预设截止标准对暴露动物进行分类。暴露后 8 天评估特定脑区的 NPY 蛋白水平。暴露后 1 小时,通过中枢给予 NPY 激动剂、NPY-Y1 受体拮抗剂或安慰剂,以相同方式评估其对行为的影响。免疫组织化学技术用于检测 NPY、NPY-Y1 受体、脑源性神经营养因子和 GR 的表达,检测时间为行为测试后 1 天。与行为轻微(MBR)或部分(PBR)中断以及未暴露对照动物相比,行为严重中断(EBR)的动物海马体、中脑导水管周围灰质和杏仁核中 NPY 的表达显著下调。与载体对照相比,暴露后 1 小时给予 NPY 治疗可显著降低 EBR 的发生率,并减少创伤线索冻结反应。与 EBR 相关的 NPY 下调的独特模式以及 NPY 药物干预的强烈行为效应表明,NPY 与应激反应的行为之间存在密切关联,并且潜在地与分子和精神病理过程之间存在关联,这些变化导致了观察到的行为变化。NPY 具有保护作用,这归因于其在严重受应激源影响的动物中表达的极度减少,这意味着其在促进适应和/或恢复方面的作用。